BN Business News
Unternehmen hinzufügen →
Diese Übersetzung wird noch vorbereitet. Bis dahin zeigen wir vorübergehend die englische Originalversion.

Geschäft · 21.5.19981 Min. Lesezeit

Guidance for Industry, Supplements to Approved Applications for Class III Medical Devices: Use of Published Literature, Use of Previously Submitted Materials, and Priority Review; Availability

Lokale automatische Übersetzung · Originalsprache der Quelle

Zusammenfassung

The Food and Drug Administration (FDA) is announcing the availability of the guidance entitled, ``Guidance for Industry, Supplements to Approved Applications for Class III Medical Devices: Use of Published Literature, Use of Previously Submitted Materials, and Priority Review.'' The FDA Modernization Act of 1997 (FDAMA) requires the agency to issue final guidance to clarify circumstances in which published matter may be the basis for approval of a supplemental application, specify data requirements that will avoid duplication of previously submitted data by recognizing the availability of data previously submitted in support of an original application and define supplemental applications that are eligible for priority review.

Originalsprache der Quelle: Federal Register — Food and Drug AdministrationOriginalquelle öffnen →

Weitere Themen

Business-Analysen →